top of page

EMFANA

Emergency Medications for Anaesthesic Nurses Australia

** Bradycardia 

What is Atropine?

Atropine is a drug used to increase heart rate and dry up secretions. In anaesthesia, it is mainly used when a patient has a low heart rate called bradycardia (common medication used during cardiac arrest).

Common Adult Dose

  • A common adult dose is 0.5–1 mg IV for antivagal effect or to reduce secretions.

  • In cardiac arrest with bradyasystole, if label lists 1 mg IV, repeated every 3–5 minutes up to 3 mg total.

  • Always follow your local protocol, anaesthetist’s order, and check dosing.

When is it often used?

  • slow heart rate (bradycardia)

  • vagal bradycardia

  • during cardiac arrest to increase heart rate

  • a need to reduce saliva or airway secretions

  • a need to reduce muscarinic side effects from drugs such as reversal agents

TYPICAL VIALS AVAILABLE

  • If the atropine ampoule says 600 micrograms in 1 mL, then 1 mL will give 0.6 mg dose

  • If the atropine ampoule says 1.2 mg in 1 mL, then 0.5 mL will give 0.6 mg dose

  • If the atropine ampoule says 1.2 mg in 1 mL, then 1 mL will give 1.2 mg

EXAMPLES OF PREPARE ATROPINE

  • Usually atropine is given as direct IV injection during an emergency

  • If smaller doses required, dilute 600mcg of atropine with 5ml of 0.9% sodium chloride (giving 100micrograms/ml and a total of 6ml of fluid - you will need a 10ml syringe for this)

What usually happens after atropine administration?

The patient’s heart rate should rise. Secretions may reduce. It is not mainly used to raise blood pressure.

  • tachycardia

  • dry mouth

  • blurred vision

  • urinary retention

  • less sweating

This website is provided for general educational and informational purposes only. It is not intended to replace hospital policy, clinical judgment, official guidelines, medication charts, or advice from a qualified medical practitioner. Users are solely responsible for verifying all drug information, dosages, indications, contraindications, and administration requirements before clinical use. The owners and authors of this website accept no liability for any loss, injury, or damage arising from reliance on the information provided.

bottom of page